Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia? (Q33493613)

27 July 2017

title

Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia? (English)

1 reference

27 July 2017

1 reference

1 reference

1 reference

Lennard L

1

1 reference

27 July 2017

Davies HA

series ordinal

2

1 reference

27 July 2017

Lilleyman JS

series ordinal

3

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 July 1993

1 reference

British Journal of Cancer

27 July 2017

published in

1 reference

27 July 2017

volume

68

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

186-190

1 reference

Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

Pharmacology of 6-thioguanine in man.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

Hepatotoxic effects of oncotherapeutic agents

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

Which treatment for childhood acute lymphoblastic leukaemia in second remission?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

A-phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma. A Southwest Oncology Group study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

Lessons from 20 years of curative therapy of childhood acute leukaemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

A reliable method for evaluating drug compliance in children with cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

Portal hypertension in a patient with chronic myeloid leukaemia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

Pharmacokinetics and metabolism of beta-2'-deoxythioguanosine and 6-thioguanine in man.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968314

Clinical and pharmacologic effects of combinations of 6-thioguanine and duazomycin A in patients with neoplastic disease

31 October 2018

1 reference

12 December 2020

High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample

1 reference

12 December 2020

Clinical pharmacology of oral thioguanine in acute myelogenous leukemia

1 reference

12 December 2020

Phase II evaluation and plasma pharmacokinetics of high-dose intravenous 6-thioguanine in patients with colorectal carcinoma

1 reference

12 December 2020

Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol

1 reference

12 December 2020

Phase I trial of parenteral 6-thioguanine given on 5 consecutive days

1 reference

12 December 2020

Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia

1 reference

12 December 2020

Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1993.311

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference

27 July 2017

1 reference